• Horizon Discovery Ltd., of Cambridge, UK, said it has established a Center of Excellence for gene editing at the University of Leicester, UK. The program will focus on the creation of isogenic cell lines that contain "risk" or "protective" SNPs associated with cardiovascular disease, identified from genomewide association studies.